- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 1, 2025 | 20.61M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 20.12M sh |
| Capex | FY 2024 · Dec 31, 2023 | $259K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$1.36M |
| Short Term Debt restated | FY 2024 · Dec 31, 2023 | $1.16M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $324K |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $44.93M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $110.84M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $60.61M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $177.12M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.36 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.36 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $37.67M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$7.29M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | $2.83M |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | $50.07M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $288.38M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $71.14M |